… nanoparticles and enhanced sustained activity and bioavailability were observed in contrast
with plain gliclazide in the streptozotocin-… , embedded in the lipid nanoparticles (SLNs and …

… was to use Zinc oxide nanoparticles and a standard … nanoparticles (ZnONPs) using a model
of type 2 diabetes (rats fed a high fat diet that was treated with a low dose of streptozotocin). …

… effect of nanothymoquinone in streptozotocin-nicotinamide induced type-2 diabetes in rats
… Solid lipid nanoparticles and nanostructured lipid carriers of tolnaftate: design, optimization …

… In this study, an observable serum lipid profiles in HFD/STZ induced diabetic rats was
observed. Whereas, the oral CTS-Se-NPs administration even through monotherapy and …

… Solid lipid nanoparticles have enormous effect in loading … Nicotinamide solution: Nicotinamide
arrangement was newly … course and following 15 minutes, Streptozotocin 60 mg/kg IP. …

Background Diabetic Mellitus is characterized by a lack or failure of insulin to bind to its
target receptor or failure of the pancreas to yield insulin. This study evaluated the …

… The diabetic rat model was intraperitoneally induced by streptozotocin (STZ, 65 mg/kg) and
nicotinamide (NA, 230 mg/kg) according to a previous method. The diabetes condition was …

… kidneys and lowered the level of transaminases, lipids, nitrogenous compounds and pro-inflammatory
cytokines in the serum of STZ-nicotinamide prompted diabetic rats. Decrease in …

… The treatment agents also suppressed the elevated lipid … by a single intraperitoneal (ip)
STZ injection (50 mg/kg b. wt.; … Seven days after NA/STZ injection, fasting blood glucose …

… Nicotinamide followed by STZ (intraperitoneally) was used to induce experimental DM in
rats in this study. STZ contains a nitroso moiety and liberates nitric oxide and free radicals, …